Home › Asset managers › Compare 2024-2025 › Brighthouse vs Jackson National
Note on Brighthouse: its funds did not all vote the same way on 14.7% of the 97,681 ballot items it voted. Those items are not in the percentage above; the ones it shares with this pair are listed under “Split votes”.
Brighthouse 2024-2025 · Jackson National 2024-2025 · Download the item list (CSV)
| Common items | Same | Differ | Split (not in %) | Same position | Fund-level | |
|---|---|---|---|---|---|---|
| All ballot items | 13,515 | 7,832 | 474 | 5,209 | 94.3% | 81.5% |
| Board proposals | 10,896 | 6,126 | 428 | 4,342 | 93.5% | 81.2% |
| E&S shareholder proposals | 255 | 2 | 3 | 250 | 40.0% | 40.6% |
| Other items | 2,364 | 1,704 | 43 | 617 | 97.5% | 87.2% |
Everything Voted differently Split votes
All ballot items Board proposals E&S shareholder proposals Other items
4,342 items. “Voted differently”: each manager’s funds all voted one way, and the two ways differ. “Split”: at least one manager’s funds did not all vote the same way.
| Company | Meeting | Proposal | On the ballot from | Board recommended | Brighthouse | Jackson National |
|---|---|---|---|---|---|---|
| CRH PLC | May 8, 2025 | Consideration of Named Executive Officer Compensation for 2024 ("Say-on-Pay") Say-on-Pay |
Board | For | Split 2 FOR, 1 AGAINST |
FOR 10 funds |
| CRINETICS PHARMACEUTICALS INC. | June 11, 2025 | To consider and vote upon the ratification of the selection of BDO USA, P.C. as our independent registered public accounting firm for the fiscal year ending December 31, 2025. Audit-related |
Board | For | Split 5 FOR, 1 ABSTAIN |
FOR 3 funds |
| CRINETICS PHARMACEUTICALS INC. | June 11, 2025 | To consider and vote upon, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the proxy statement pursuant to the compensation disclosure rules of the Securities and Exchange Commission. Say-on-Pay |
Board | For | Split 5 FOR, 1 ABSTAIN |
FOR 3 funds |
| CROCS INC. | June 10, 2025 | An advisory vote to approve the compensation of our named executive officers. Say-on-Pay |
Board | For | Split 6 FOR, 2 ABSTAIN |
FOR 6 funds |
| CROCS INC. | June 10, 2025 | Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for fiscal year 2025. Audit-related |
Board | For | Split 6 FOR, 2 ABSTAIN |
FOR 6 funds |
| CROWDSTRIKE HOLDINGS INC. | June 18, 2025 | To ratify the selection of PricewaterhouseCoopers LLP as CrowdStrike's independent registered public accounting firm for its fiscal year ending January 31, 2026. Audit-related |
Board | For | Split 8 FOR, 2 ABSTAIN |
FOR 16 funds |
| CROWN CASTLE INC. | May 21, 2025 | The non-binding, advisory vote to approve the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | Split 6 FOR, 1 AGAINST, 2 ABSTAIN |
Split 7 FOR, 7 AGAINST |
| CROWN CASTLE INC. | May 21, 2025 | The ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accountants for fiscal year 2025. Audit-related |
Board | For | Split 7 FOR, 2 ABSTAIN |
FOR 14 funds |
| CROWN HOLDINGS INC. | May 1, 2025 | Approval by advisory vote of the resolution on executive compensation as described in the Proxy Statement. Say-on-Pay |
Board | For | Split 4 FOR, 4 ABSTAIN |
FOR 11 funds |
| CROWN HOLDINGS INC. | May 1, 2025 | Ratification of the appointment of independent auditors for the fiscal year ending December 31, 2025. Audit-related |
Board | For | Split 4 FOR, 4 ABSTAIN |
Split 10 FOR, 1 AGAINST |
| CRYOPORT INC. | June 6, 2025 | To ratify the appointment of Deloitte & Touche LLP as the independent registered public accounting firm of the Company and its subsidiaries for the year ending December 31, 2025. Audit-related |
Board | For | Split 4 FOR, 1 ABSTAIN |
FOR 2 funds |
| CSG SYSTEMS INTERNATIONAL INC. | May 14, 2025 | To approve, on an advisory basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | Split 4 FOR, 2 ABSTAIN |
FOR 5 funds |
| CSG SYSTEMS INTERNATIONAL INC. | May 14, 2025 | To ratify the appointment of KPMG LLP as our independent registered public accounting firm for fiscal 2025. Audit-related |
Board | For | Split 4 FOR, 2 ABSTAIN |
FOR 5 funds |
| CSW INDUST | August 15, 2024 | Approval, by non-binding vote, of executive compensation. Say-on-Pay |
Board | Not determined | Split 5 FOR, 1 ABSTAIN |
FOR 6 funds |
| CSW INDUST | August 15, 2024 | The ratification of Grant Thornton LLP to serve as independent registered public accounting firm for the fiscal year ending March 31, 2025. Audit-related |
Board | Not determined | Split 5 FOR, 1 ABSTAIN |
FOR 6 funds |
| CSX CORP. | May 7, 2025 | Advisory (non-binding) resolution to approve compensation for the Company's named executive officers. Say-on-Pay |
Board | For | Split 8 FOR, 1 AGAINST, 3 ABSTAIN |
Split 16 FOR, 1 AGAINST |
| CSX CORP. | May 7, 2025 | The ratification of the appointment of Ernst & Young LLP as the Independent Registered Public Accounting Firm for 2025. Audit-related |
Board | For | Split 8 FOR, 1 AGAINST, 3 ABSTAIN |
Split 15 FOR, 2 AGAINST |
| CTS CORP. | May 8, 2025 | Approval, on an advisory basis, of the compensation of CTS' named executive officers. Say-on-Pay |
Board | For | Split 3 FOR, 1 ABSTAIN |
FOR 3 funds |
| CTS CORP. | May 8, 2025 | Ratification of the appointment of Grant Thornton LLP as CTS' independent auditor for 2025. Audit-related |
Board | For | Split 3 FOR, 1 ABSTAIN |
FOR 3 funds |
| CUBESMART | May 20, 2025 | To amend and restate the Amended and Restated CubeSmart 2007 Equity Incentive Plan. Compensation |
Board | For | Split 6 FOR, 5 ABSTAIN |
FOR 6 funds |
| CUBESMART | May 20, 2025 | To cast an advisory vote to approve our executive compensation. Say-on-Pay |
Board | For | Split 6 FOR, 5 ABSTAIN |
FOR 6 funds |
| CUBESMART | May 20, 2025 | To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the year ending December 31, 2025. Audit-related |
Board | For | Split 6 FOR, 5 ABSTAIN |
FOR 6 funds |
| CULLEN/FROST BANKERS INC. | April 30, 2025 | To provide nonbinding approval of executive compensation. Say-on-Pay |
Board | For | Split 1 FOR, 1 ABSTAIN |
Split 3 FOR, 5 AGAINST |
| CULLEN/FROST BANKERS INC. | April 30, 2025 | To ratify the selection of Ernst & Young LLP to act as independent auditors of Cullen/Frost for the fiscal year that began January 1, 2025. Audit-related |
Board | For | Split 3 FOR, 1 ABSTAIN |
FOR 8 funds |
| CULLINAN THERAPEUTICS INC. | June 12, 2025 | Proposal to ratify the appointment of KPMG LLP as Cullinan Therapeutics' independent registered public accounting firm for the fiscal year ending December 31, 2025. Audit-related |
Board | For | Split 1 FOR, 1 ABSTAIN |
FOR 1 fund |
| CULLINAN THERAPEUTICS INC. | June 12, 2025 | Proposal to vote, on an advisory basis, to approve our named executive officer compensation. Say-on-Pay |
Board | For | Split 1 FOR, 1 ABSTAIN |
FOR 1 fund |
| CUMMINS INC. | May 13, 2025 | Advisory vote to approve the compensation of our named executive officers as disclosed in the proxy statement. Say-on-Pay |
Board | For | Split 9 FOR, 5 ABSTAIN |
FOR 10 funds |
| CUMMINS INC. | May 13, 2025 | Proposal to ratify the appointment of PricewaterhouseCoopers LLP as our auditors for 2025. Audit-related |
Board | For | Split 8 FOR, 1 AGAINST, 5 ABSTAIN |
FOR 10 funds |
| CURTISS-WRIGHT CORP. | May 8, 2025 | An advisory (non-binding) vote to approve the compensation of the Company's named executive officers Say-on-Pay |
Board | For | Split 4 FOR, 4 ABSTAIN |
FOR 7 funds |
| CURTISS-WRIGHT CORP. | May 8, 2025 | To ratify the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for 2025 Audit-related |
Board | For | Split 4 FOR, 4 ABSTAIN |
FOR 7 funds |
| CUSHMAN & WAKEFIELD PLC | May 15, 2025 | Approval of an amendment to our Omnibus Management Share and Cash Incentive Plan. Compensation |
Board | For | Split 6 FOR, 1 ABSTAIN |
Split 3 FOR, 2 AGAINST |
| CUSHMAN & WAKEFIELD PLC | May 15, 2025 | Authorization of the Audit Committee to determine the compensation of our U.K. Statutory Auditor. Audit-related |
Board | For | Split 6 FOR, 1 ABSTAIN |
FOR 5 funds |
| CUSHMAN & WAKEFIELD PLC | May 15, 2025 | Non-binding, advisory vote on the compensation of our Named Executive Officers ("Say-on-Pay"). Say-on-Pay |
Board | For | Split 6 FOR, 1 ABSTAIN |
FOR 5 funds |
| CUSHMAN & WAKEFIELD PLC | May 15, 2025 | Ratification of KPMG LLP as independent registered public accounting firm. Audit-related |
Board | For | Split 6 FOR, 1 ABSTAIN |
FOR 5 funds |
| CUSTOMERS BANCORP INC. | May 27, 2025 | To approve a non-binding advisory resolution on named executive officer compensation. Say-on-Pay |
Board | For | Split 6 FOR, 1 ABSTAIN |
FOR 3 funds |
| CUSTOMERS BANCORP INC. | May 27, 2025 | To ratify the appointment of Deloitte & Touche LLP as independent registered public accounting firm of the Company for the fiscal year ending December 31, 2025. Audit-related |
Board | For | Split 6 FOR, 1 ABSTAIN |
FOR 3 funds |
| CVB FINANCIAL CORP. | May 21, 2025 | To approve, on a non-binding advisory basis, the compensation of CVB Financial Corp.'s named executive officers ("Say-On-Pay") Say-on-Pay |
Board | For | Split 3 FOR, 1 ABSTAIN |
FOR 4 funds |
| CVB FINANCIAL CORP. | May 21, 2025 | To ratify the appointment of KPMG LLP as independent registered public accountants of CVB Financial Corp. for the year ending December 31, 2025. Audit-related |
Board | For | Split 3 FOR, 1 ABSTAIN |
FOR 4 funds |
| CVR ENERGY INC. | June 5, 2025 | To approve the Third Amended & Restated CVR Energy, Inc. 2007 Long-Term Incentive Plan. Compensation |
Board | For | Split 1 FOR, 4 AGAINST, 1 ABSTAIN |
Split 1 FOR, 5 AGAINST |
| CVR ENERGY INC. | June 5, 2025 | To approve, on an advisory basis, our named executive officer compensation. Say-on-Pay |
Board | For | Split 1 FOR, 4 AGAINST, 1 ABSTAIN |
Split 1 FOR, 5 AGAINST |
| CVS HEALTH CORP. | May 15, 2025 | Ratification of the Appointment of Our Independent Registered Public Accounting Firm for 2025. Audit-related |
Board | For | Split 7 FOR, 1 ABSTAIN |
FOR 13 funds |
| CVS HEALTH CORP. | May 15, 2025 | Say on Pay, a Proposal to Approve, on an Advisory Basis, the Company's Executive Compensation. Shareholder Rights and Defenses |
Board | For | Split 2 FOR, 5 AGAINST, 1 ABSTAIN |
Split 11 FOR, 2 AGAINST |
| CYBERARK SOFTWARE LTD. | June 24, 2025 | To approve the re-appointment of Kost Forer Gabbay & Kasierer, registered public accounting firm, a member firm of Ernst & Young Global, as the Company's independent registered public accounting firm for the year ending December 31, 2025, and until the Company's 2026 annual general meeting of shareholders, and to authorize the Board to fix such accounting firm's annual compensation. Audit-related |
Board | For | ABSTAIN 2 funds |
Split 3 FOR, 1 AGAINST |
| CYTOKINETICS INC. | May 14, 2025 | To approve an amendment to Cytokinetics, Incorporated's Amended and Restated Certificate of Incorporation to increase the number of authorized shares of common available for issuance by Cytokinetics, Incorporated from 163,000,000 to 326,000,000 shares of common stock. Capital Structure |
Board | For | Split 7 FOR, 5 AGAINST |
FOR 6 funds |
| CYTOKINETICS INC. | May 14, 2025 | To approve the amendment and restatement of the Cytokinetics Amended and Restated 2004 Equity Incentive Plan to: (i) increase the number of authorized shares reserved for issuance under such plan by 5,000,000 shares of common stock and (ii) provide for limitations on the maximum grant value that non-executive directors may receive under such plan of $1,000,000 for annual grants to continuing directors and $1,250,000 for the initial grant to new directors. Compensation |
Board | For | Split 7 FOR, 5 ABSTAIN |
FOR 6 funds |
| CYTOKINETICS INC. | May 14, 2025 | To approve, on an advisory basis, the compensation of Cytokinetics, Incorporated's named executive officers, as disclosed in the Proxy Statement. Say-on-Pay |
Board | For | Split 7 FOR, 5 ABSTAIN |
FOR 6 funds |
| CYTOKINETICS INC. | May 14, 2025 | To ratify the appointment by the Audit Committee of the Board of Directors of Ernst & Young LLP as Cytokinetics, Incorporated's independent registered public accounting firm for the fiscal year ending December 31, 2025. Audit-related |
Board | For | Split 7 FOR, 5 ABSTAIN |
FOR 6 funds |
| D.R. HORTON INC. | January 16, 2025 | Approval of the advisory resolution on executive compensation. Say-on-Pay |
Board | For | Split 5 FOR, 1 AGAINST, 7 ABSTAIN |
FOR 10 funds |
| D.R. HORTON INC. | January 16, 2025 | Ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm. Audit-related |
Board | For | Split 6 FOR, 7 ABSTAIN |
FOR 10 funds |
| DANA INC. | April 24, 2025 | Approval of a non-binding advisory proposal approving executive compensation. Say-on-Pay |
Board | For | Split 6 FOR, 1 ABSTAIN |
AGAINST 5 funds |
| DANA INC. | April 24, 2025 | Approval of the amendment to the Dana Incorporated 2021 Omnibus Incentive Plan. Compensation |
Board | For | Split 6 FOR, 1 ABSTAIN |
FOR 5 funds |
| DANA INC. | April 24, 2025 | Ratification of the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm. Audit-related |
Board | For | Split 6 FOR, 1 ABSTAIN |
FOR 5 funds |
| DANAHER CORP. | May 6, 2025 | To approve on an advisory basis the Company's named executive officer compensation. Say-on-Pay |
Board | For | Split 16 FOR, 1 AGAINST, 3 ABSTAIN |
FOR 17 funds |
| DANAHER CORP. | May 6, 2025 | To ratify the selection of Ernst & Young LLP as Danaher's independent registered public accounting firm for the year ending December 31, 2025. Audit-related |
Board | For | Split 16 FOR, 1 AGAINST, 3 ABSTAIN |
FOR 17 funds |
| DARDEN RESTAURANTS INC. | September 18, 2024 | To obtain non-binding advisory approval of the Company's executive compensation. Say-on-Pay |
Board | For | Split 7 FOR, 3 ABSTAIN |
Split 10 FOR, 1 AGAINST |
| DARDEN RESTAURANTS INC. | September 18, 2024 | To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending May 25, 2025. Audit-related |
Board | For | Split 7 FOR, 3 ABSTAIN |
FOR 11 funds |
| DARLING INGREDIENTS INC. | May 7, 2025 | Advisory vote to approve, on an advisory basis, executive compensation. Say-on-Pay |
Board | For | Split 3 FOR, 2 ABSTAIN |
FOR 7 funds |
| DARLING INGREDIENTS INC. | May 7, 2025 | Proposal to ratify the selection of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending January 3, 2026. Audit-related |
Board | For | Split 3 FOR, 2 ABSTAIN |
FOR 7 funds |
| DASSAULT SYSTEMES | May 22, 2025 | APPROVAL OF THE INFORMATION CONTAINED IN THE CORPORATE GOVERNANCE REPORT AND RELATING TO THE COMPENSATION OF CORPORATE OFFICERS (MANDATAIRES SOCIAUX) (ARTICLE L. 22-10-9 OF THE FRENCH COMMERCIAL CODE) Compensation |
Board | Not determined | AGAINST 1 fund |
Split 1 FOR, 4 AGAINST |
| DASSAULT SYSTEMES | May 22, 2025 | COMPENSATION ELEMENTS PAID IN 2024 OR GRANTED FOR FISCAL YEAR 2024 TO MR. BERNARD CHARLES, CHAIRMAN OF THE BOARD OF DIRECTORS Say-on-Pay |
Board | Not determined | AGAINST 1 fund |
Split 3 FOR, 2 AGAINST |
| DASSAULT SYSTEMES | May 22, 2025 | COMPENSATION ELEMENTS PAID IN 2024 OR GRANTED FOR FISCAL YEAR 2024 TO MR. PASCAL DALOZ, CHIEF EXECUTIVE OFFICER Say-on-Pay |
Board | Not determined | AGAINST 1 fund |
Split 4 FOR, 1 AGAINST |
| DASSAULT SYSTEMES | May 22, 2025 | COMPENSATION POLICY FOR CORPORATE OFFICERS (MANDATAIRES SOCIAUX) Compensation |
Board | Not determined | AGAINST 1 fund |
Split 4 FOR, 1 AGAINST |
| DASSAULT SYSTEMES | May 22, 2025 | NOMINATION OF MS. MARIE-HELENE HABERT-DASSAULT AS DIRECTOR Director Elections |
Board | Not determined | FOR 1 fund |
Split 2 FOR, 3 AGAINST |
| DASSAULT SYSTEMES | May 22, 2025 | REAPPOINTMENT OF MR. SOUMITRA DUTTA Director Elections |
Board | Not determined | FOR 1 fund |
Split 4 FOR, 1 AGAINST |
| DATADOG | June 3, 2025 | Advisory vote to approve the compensation of our named executive officers. Say-on-Pay |
Board | For | Split 5 FOR, 3 ABSTAIN |
Split 7 FOR, 6 AGAINST |
| DATADOG | June 3, 2025 | To ratify the selection by the Audit Committee of our Board of Directors of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025. Audit-related |
Board | For | Split 5 FOR, 3 ABSTAIN |
FOR 13 funds |
| DAVITA INC. | June 5, 2025 | To approve, on an advisory basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | Split 5 FOR, 1 AGAINST, 2 ABSTAIN |
Split 1 FOR, 6 AGAINST |
| DAVITA INC. | June 5, 2025 | To ratify the appointment of KPMG LLP as our independent registered public accounting firm for fiscal year 2025. Audit-related |
Board | For | Split 5 FOR, 1 AGAINST, 2 ABSTAIN |
FOR 7 funds |
| DAY ONE BIOPHARMACEUTICALS INC. | June 2, 2025 | Approval, on a non-binding advisory basis, of the compensation of our named executive officers. Say-on-Pay |
Board | For | Split 1 FOR, 1 ABSTAIN |
FOR 2 funds |
| DAY ONE BIOPHARMACEUTICALS INC. | June 2, 2025 | Ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the year ending December 31, 2025. Audit-related |
Board | For | Split 1 FOR, 1 ABSTAIN |
FOR 2 funds |
| DAYFORCE INC. | May 2, 2025 | To approve, on a non-binding, advisory basis, the compensation of Dayforce's named executive officers (commonly known as a "Say on Pay" vote) Say-on-Pay |
Board | For | Split 5 FOR, 1 ABSTAIN |
Split 5 FOR, 2 AGAINST |
| DAYFORCE INC. | May 2, 2025 | To ratify the appointment of KPMG LLP as Dayforce's independent registered public accounting firm for the fiscal year ending December 31, 2025 Audit-related |
Board | For | Split 5 FOR, 1 ABSTAIN |
FOR 7 funds |
| DECKERS OUTDOOR CORP. | September 9, 2024 | To approve the adoption of the 2024 Employee Stock Purchase Plan. Compensation |
Board | For | Split 6 FOR, 3 AGAINST |
FOR 11 funds |
| DECKERS OUTDOOR CORP. | September 9, 2024 | To approve the amendment of certificate of incorporation to effect a six-for-one stock split with proportionate increase in authorized capital stock. Capital Structure |
Board | For | Split 5 FOR, 1 AGAINST, 3 ABSTAIN |
FOR 11 funds |
| DECKERS OUTDOOR CORP. | September 9, 2024 | To approve, on a non-binding advisory basis, the compensation of our Named Executive Officers, as described in the section of the Proxy Statement entitled "Compensation Discussion and Analysis". Say-on-Pay |
Board | For | Split 6 FOR, 3 ABSTAIN |
Split 3 FOR, 8 AGAINST |
| DECKERS OUTDOOR CORP. | September 9, 2024 | To ratify the selection of KPMG LLP as our independent registered public accounting firm for our fiscal year ending March 31, 2025. Audit-related |
Board | For | Split 6 FOR, 3 ABSTAIN |
FOR 11 funds |
| DEERE & CO. | February 26, 2025 | Advisory vote to approve executive compensation ("say-on-pay") Say-on-Pay |
Board | For | Split 8 FOR, 1 AGAINST, 2 ABSTAIN |
FOR 17 funds |
| DEERE & CO. | February 26, 2025 | Ratification of the appointment of Deloitte & Touche LLP as Deere's independent registered public accounting firm for fiscal 2025 Audit-related |
Board | For | Split 8 FOR, 1 AGAINST, 2 ABSTAIN |
FOR 17 funds |
| DELEK US HOLDINGS INC. | April 29, 2025 | Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the 2025 fiscal year. Audit-related |
Board | For | Split 5 FOR, 1 ABSTAIN |
FOR 5 funds |
| DELEK US HOLDINGS INC. | April 29, 2025 | To adopt the advisory resolution approving the executive compensation program for our named executive officers as described in the Proxy Statement. Say-on-Pay |
Board | For | Split 5 FOR, 1 ABSTAIN |
FOR 5 funds |
| DELEK US HOLDINGS INC. | April 29, 2025 | To approve the amendment to the 2016 Long-Term Incentive Plan to increase the number of shares available for issuance thereunder. Compensation |
Board | For | Split 5 FOR, 1 ABSTAIN |
FOR 5 funds |
| DELL TECHNOLOGIES INC. | June 26, 2025 | Approval, on a non-binding, advisory basis, of the compensation of Dell Technologies Inc.'s named executive officers as disclosed in the proxy statement Say-on-Pay |
Board | For | Split 1 AGAINST, 1 ABSTAIN |
FOR 9 funds |
| DELL TECHNOLOGIES INC. | June 26, 2025 | Ratification of the appointment of PricewaterhouseCoopers LLP as Dell Technologies Inc.'s independent registered public accounting firm for the fiscal year ending January 30, 2026 Audit-related |
Board | For | Split 4 FOR, 1 AGAINST, 1 ABSTAIN |
FOR 9 funds |
| DELTA AIR LINES INC. | June 19, 2025 | To approve the amendment and restatement of Delta's Performance Compensation Plan. Compensation |
Board | For | Split 5 FOR, 5 ABSTAIN |
FOR 15 funds |
| DELTA AIR LINES INC. | June 19, 2025 | To approve, on an advisory basis, the compensation of Delta's named executive officers. Say-on-Pay |
Board | For | Split 5 FOR, 5 ABSTAIN |
FOR 15 funds |
| DELTA AIR LINES INC. | June 19, 2025 | To ratify the appointment of Ernst & Young LLP as Delta's independent auditors for the year ending December 31, 2025. Shareholder Rights and Defenses |
Board | For | Split 5 FOR, 5 ABSTAIN |
FOR 15 funds |
| DELUXE CORP. | April 24, 2025 | Advisory vote (non-binding) to approve the compensation of our Named Executive Officers. Say-on-Pay |
Board | For | Split 2 FOR, 1 ABSTAIN |
FOR 3 funds |
| DELUXE CORP. | April 24, 2025 | Approval of Amendment No. 2 to the Deluxe Corporation 2022 Stock Incentive Plan. Compensation |
Board | For | Split 2 FOR, 1 ABSTAIN |
FOR 3 funds |
| DELUXE CORP. | April 24, 2025 | Ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025. Audit-related |
Board | For | Split 2 FOR, 1 ABSTAIN |
FOR 3 funds |
| DENALI THERAPEUTICS | June 3, 2025 | Advisory vote on executive compensation Say-on-Pay |
Board | For | Split 4 FOR, 3 ABSTAIN |
FOR 4 funds |
| DENALI THERAPEUTICS | June 3, 2025 | Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2025 Audit-related |
Board | For | Split 4 FOR, 3 ABSTAIN |
FOR 4 funds |
| DENTSPLY SIRONA INC. | May 21, 2025 | Approval of Amendment No. 1 to the 2024 Omnibus Incentive Plan to increase the number of shares of the Company's Common Stock issuable under such Plan. Compensation |
Board | For | Split 2 FOR, 1 ABSTAIN |
FOR 9 funds |
| DENTSPLY SIRONA INC. | May 21, 2025 | Approval, by non-binding vote, of the Company's executive compensation for 2024. Say-on-Pay |
Board | For | Split 2 FOR, 1 ABSTAIN |
FOR 9 funds |
| DENTSPLY SIRONA INC. | May 21, 2025 | Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accountants for 2025. Audit-related |
Board | For | Split 2 FOR, 1 ABSTAIN |
FOR 9 funds |
| DEUTSCHE POST AG | May 2, 2025 | ELECT LAWRENCE ROSEN TO THE SUPERVISORY BOARD Director Elections |
Board | For | Split 3 FOR, 1 AGAINST |
Split 2 FOR, 1 AGAINST |
| DEVON ENERGY CORP. | June 4, 2025 | Advisory Vote to Approve Executive Compensation. Say-on-Pay |
Board | For | Split 6 AGAINST, 5 ABSTAIN |
AGAINST 8 funds |
| DEVON ENERGY CORP. | June 4, 2025 | Ratification of the Selection of KPMG as the Company's Independent Auditor for 2025. Audit-related |
Board | For | Split 6 FOR, 5 ABSTAIN |
FOR 8 funds |
| DEXCOM INC. | May 8, 2025 | To approve our Amended and Restated 2015 Employee Stock Purchase Plan to, among other things, increase the number of shares reserved for issuance thereunder by 8,000,000 shares. Compensation |
Board | For | Split 11 FOR, 3 AGAINST |
FOR 13 funds |
| DEXCOM INC. | May 8, 2025 | To approve our Amended and Restated 2015 Equity Incentive Plan (as amended and restated) to, among other things, increase the number of shares reserved for issuance thereunder by 3,400,000 shares. Compensation |
Board | For | Split 11 FOR, 3 ABSTAIN |
FOR 13 funds |
| DEXCOM INC. | May 8, 2025 | To provide a non-binding advisory vote on the compensation of our named executive officers for the fiscal year ended December 31, 2024. Say-on-Pay |
Board | For | Split 10 FOR, 1 AGAINST, 3 ABSTAIN |
Split 5 FOR, 8 AGAINST |
← Previous Page 12 of 44 Next →
How items are matched and positions counted: see the comparison table and the methodology. Built November 1, 2026 from SEC Form N-PX filings.